Similar articles

• [Seroepidemiology of the HTLV-III virus in a high-risk Panamanian population. Preliminary report].

  Arosemena JR, Cuevas M, Ulloa E, Guerrero DM, Gómez B, Cantón-Dutary A, Reyes R, Quiroz E, de Britton RM, Brenes MM, et al. Arosemena JR, et al. Rev Med Panama. 1986 May;11(2):124-33. Rev Med Panama. 1986. PMID: 3018847 Spanish. No abstract available.
• Longitudinal serologic evaluation of an infant with acquired immunodeficiency syndrome.

  Krilov LR, Kamani N, Hendry RM, Wittek AE, Quinnan GV Jr. Krilov LR, et al. Pediatr Infect Dis J. 1987 Nov;6(11):1066-7. Pediatr Infect Dis J. 1987. PMID: 3480501 No abstract available.
• [Detection of anti-p24 in patients with acquired immunodeficiency syndrome].

  Soriano V, Tor J, Muga R, Clotet B. Soriano V, et al. Med Clin (Barc). 1988 Apr 23;90(16):676-7. Med Clin (Barc). 1988. PMID: 3165154 Spanish. No abstract available.
• [Lymphopathic HTLV-III-LAV infection and acquired immunodeficiency syndrome].

  Pokrovskiĭ VV. Pokrovskiĭ VV. Ter Arkh. 1986;58(10):151-4. Ter Arkh. 1986. PMID: 3541273 Review. Russian. No abstract available.
• [Quantitation of and neutralizing antibodies to AIDS-retroviruses; a novel system using HTLV-I carrying MT-4 cells].

  Harada S, Yamamoto N. Harada S, et al. Tanpakushitsu Kakusan Koso. 1985 Dec;30(13):1394-407. Tanpakushitsu Kakusan Koso. 1985. PMID: 3003812 Review. Japanese. No abstract available.